maxim 4dMaxim raised the firm's price target on Nutex Health (NUTX) to $225 from $100 and keeps a Buy rating on the shares. The company's Q1 resultsMaxim raised the firm's price target on Nutex Health (NUTX) to $225 from $100 and keeps a Buy rating on the shares. The company's Q1 results